155 related articles for article (PubMed ID: 9933646)
1. Identification of the tissue inhibitor of metalloproteinases-2 (TIMP-2) binding site on the hemopexin carboxyl domain of human gelatinase A by site-directed mutagenesis. The hierarchical role in binding TIMP-2 of the unique cationic clusters of hemopexin modules III and IV.
Overall CM; King AE; Sam DK; Ong AD; Lau TT; Wallon UM; DeClerck YA; Atherstone J
J Biol Chem; 1999 Feb; 274(7):4421-9. PubMed ID: 9933646
[TBL] [Abstract][Full Text] [Related]
2. Specific, high affinity binding of tissue inhibitor of metalloproteinases-4 (TIMP-4) to the COOH-terminal hemopexin-like domain of human gelatinase A. TIMP-4 binds progelatinase A and the COOH-terminal domain in a similar manner to TIMP-2.
Bigg HF; Shi YE; Liu YE; Steffensen B; Overall CM
J Biol Chem; 1997 Jun; 272(24):15496-500. PubMed ID: 9182583
[TBL] [Abstract][Full Text] [Related]
3. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
[TBL] [Abstract][Full Text] [Related]
4. Identification of the TIMP-2 binding site on the gelatinase A hemopexin C-domain by site-directed mutagenesis and the yeast two-hybrid system.
Overall CM; King AE; Bigg HF; McQuibban A; Atherstone J; Sam DK; Ong AD; Lau TT; Wallon UM; DeClerck YA; Tam E
Ann N Y Acad Sci; 1999 Jun; 878():747-53. PubMed ID: 10415826
[No Abstract] [Full Text] [Related]
5. Cellular activation of MMP-2 (gelatinase A) by MT2-MMP occurs via a TIMP-2-independent pathway.
Morrison CJ; Butler GS; Bigg HF; Roberts CR; Soloway PD; Overall CM
J Biol Chem; 2001 Dec; 276(50):47402-10. PubMed ID: 11584019
[TBL] [Abstract][Full Text] [Related]
6. Domain interactions in the gelatinase A.TIMP-2.MT1-MMP activation complex. The ectodomain of the 44-kDa form of membrane type-1 matrix metalloproteinase does not modulate gelatinase A activation.
Overall CM; Tam E; McQuibban GA; Morrison C; Wallon UM; Bigg HF; King AE; Roberts CR
J Biol Chem; 2000 Dec; 275(50):39497-506. PubMed ID: 10991943
[TBL] [Abstract][Full Text] [Related]
7. Reactive site-modified tissue inhibitor of metalloproteinases-2 inhibits the cell-mediated activation of progelatinase A.
Higashi S; Miyazaki K
J Biol Chem; 1999 Apr; 274(15):10497-504. PubMed ID: 10187841
[TBL] [Abstract][Full Text] [Related]
8. Utilization of a novel recombinant myoglobin fusion protein expression system to characterize the tissue inhibitor of metalloproteinase (TIMP)-4 and TIMP-2 C-terminal domain and tails by mutagenesis. The importance of acidic residues in binding the MMP-2 hemopexin C-domain.
Kai HS; Butler GS; Morrison CJ; King AE; Pelman GR; Overall CM
J Biol Chem; 2002 Dec; 277(50):48696-707. PubMed ID: 12374789
[TBL] [Abstract][Full Text] [Related]
9. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V
Biochem J; 2003 Jun; 372(Pt 3):799-809. PubMed ID: 12630911
[TBL] [Abstract][Full Text] [Related]
10. Different domain interactions are involved in the binding of tissue inhibitors of metalloproteinases to stromelysin-1 and gelatinase A.
Nguyen Q; Willenbrock F; Cockett MI; O'Shea M; Docherty AJ; Murphy G
Biochemistry; 1994 Mar; 33(8):2089-95. PubMed ID: 8117665
[TBL] [Abstract][Full Text] [Related]
11. Plasma membrane-bound tissue inhibitor of metalloproteinases (TIMP)-2 specifically inhibits matrix metalloproteinase 2 (gelatinase A) activated on the cell surface.
Itoh Y; Ito A; Iwata K; Tanzawa K; Mori Y; Nagase H
J Biol Chem; 1998 Sep; 273(38):24360-7. PubMed ID: 9733724
[TBL] [Abstract][Full Text] [Related]
12. Mutation of the active site glutamic acid of human gelatinase A: effects on latency, catalysis, and the binding of tissue inhibitor of metalloproteinases-1.
Crabbe T; Zucker S; Cockett MI; Willenbrock F; Tickle S; O'Connell JP; Scothern JM; Murphy G; Docherty AJ
Biochemistry; 1994 May; 33(21):6684-90. PubMed ID: 7911325
[TBL] [Abstract][Full Text] [Related]
13. TIMP independence of matrix metalloproteinase (MMP)-2 activation by membrane type 2 (MT2)-MMP is determined by contributions of both the MT2-MMP catalytic and hemopexin C domains.
Morrison CJ; Overall CM
J Biol Chem; 2006 Sep; 281(36):26528-39. PubMed ID: 16825197
[TBL] [Abstract][Full Text] [Related]
14. Human tissue inhibitor of metalloproteinases 3 interacts with both the N- and C-terminal domains of gelatinases A and B. Regulation by polyanions.
Butler GS; Apte SS; Willenbrock F; Murphy G
J Biol Chem; 1999 Apr; 274(16):10846-51. PubMed ID: 10196161
[TBL] [Abstract][Full Text] [Related]
15. The propeptide domain of membrane type 1 matrix metalloproteinase is required for binding of tissue inhibitor of metalloproteinases and for activation of pro-gelatinase A.
Cao J; Drews M; Lee HM; Conner C; Bahou WF; Zucker S
J Biol Chem; 1998 Dec; 273(52):34745-52. PubMed ID: 9856998
[TBL] [Abstract][Full Text] [Related]
16. The hemopexin-like domain (C domain) of human gelatinase A (matrix metalloproteinase-2) requires Ca2+ for fibronectin and heparin binding. Binding properties of recombinant gelatinase A C domain to extracellular matrix and basement membrane components.
Wallon UM; Overall CM
J Biol Chem; 1997 Mar; 272(11):7473-81. PubMed ID: 9054449
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor.
Fernandez-Catalan C; Bode W; Huber R; Turk D; Calvete JJ; Lichte A; Tschesche H; Maskos K
EMBO J; 1998 Sep; 17(17):5238-48. PubMed ID: 9724659
[TBL] [Abstract][Full Text] [Related]
18. Mutational study of the amino-terminal domain of human tissue inhibitor of metalloproteinases 1 (TIMP-1) locates an inhibitory region for matrix metalloproteinases.
Huang W; Meng Q; Suzuki K; Nagase H; Brew K
J Biol Chem; 1997 Aug; 272(35):22086-91. PubMed ID: 9268350
[TBL] [Abstract][Full Text] [Related]
19. Cell surface-mediated activation of progelatinase A: demonstration of the involvement of the C-terminal domain of progelatinase A in cell surface binding and activation of progelatinase A by primary fibroblasts.
Ward RV; Atkinson SJ; Reynolds JJ; Murphy G
Biochem J; 1994 Nov; 304 ( Pt 1)(Pt 1):263-9. PubMed ID: 7998943
[TBL] [Abstract][Full Text] [Related]
20. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2).
Fridman R; Toth M; Peña D; Mobashery S
Cancer Res; 1995 Jun; 55(12):2548-55. PubMed ID: 7780967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
